Howe Jolanda's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Jul 3, 2025
- Accession no.
- 0001415889-25-019378
- Filed
- Jul 3, 2025
- Trade date
- Jul 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $50.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Howe JolandaCIK 0001974200 | Officer (SVP, GLOBAL CONTROLLER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | MOption exerciseAcquired | +1,041 | –F1 | – | 3,467 | Direct | |
| Jul 2, 2025 | Common Stock | SSaleDisposed | −564 | $48.25 | −$27,213 | 2,903 | Direct | |
| Jul 3, 2025 | Common Stock | SSaleDisposed | −477 | $49.08 | −$23,411.16 | 2,426 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | MOption exerciseDisposed | −1,041 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
Referenced by the price of 1 transaction in Table I.